Case Type: Mergers & Acquisitions

Affinity Bancshares, Inc. (NASDAQ: AFBI) related to its sale to Fidelity Bancshares (N.C.), Inc. Under the terms of the proposed transaction, Affinity shareholders are expected to receive $23.00 per share in cash.

Centessa Pharmaceuticals plc (NASDAQ: CNTA) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Centessa shareholders are expected to receive $38.00 per share in cash and one non-transferable contingent value right entitling the holder to receive up to an aggregate of $9.00 subject to the achievement of certain milestones.

Kezar Life Sciences, Inc. (NASDAQ: KZR) related to its sale to Aurinia Pharmaceuticals Inc. Under the terms of the proposed transaction, Kezar shareholders are expected to receive $6.955 per share in cash and one non-transferable contingent value right.

Olaplex Holdings, Inc. (NASDAQ: OLPX) related to its sale to Henkel US Operations Corporation. Under the terms of the proposed transaction, Olaplex shareholders are expected to receive $2.06 per share in cash.

Corebridge Financial, Inc. (NYSE: CRBG)  related to its merger with Equitable Holdings, Inc. Upon closing of the proposed transaction, Corebridge shareholders will own approximately 51% of the combined company.

Equitable Holdings, Inc. (NYSE: EQH) related to its merger with Corebridge Financial, Inc. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company.

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) related to its sale to Merck Sharp & Dohme LLC. Under the terms of the proposed transaction, Terns shareholders are expected to receive $53.00 per share in cash.

Warner Bros. Discovery, Inc. (NASDAQ: WBD)  related to its sale to Paramount Skydance Corporation. Under the terms of the proposed transaction, Warner Bros. shareholders are expected to receive (i) $31.00 per share in cash and (ii) a ticking consideration of $0.00277778 multiplied by the number of calendar days elapsed after September 30, 2026.

HCB Financial Corp. (OTCPK: HCBN)  related to its merger with Independent Bank Corporation. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.

Independent Bank Corporation (NASDAQ: IBCP) related to its sale to HCB Financial Corp. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.